Mutations in ASNA1 are associated with pediatric cardiomyopathy [10] and mutations in its pathway protein calcium modulating ligand (CAML) are linked in patients to hypotonia, brain abnormalities, and epilepsy [11]. Here, CAMLG is linked to epilepsy.